What is the Impact Factor of Neoplasma?

According to the latest Clarivate Journal Citation Reports (JCR), the Journal Impact Factor of Neoplasma is 2.50, ranking in quartile Q3 of Web of Science (SCIE).

Is Neoplasma indexed in Web of Science or Scopus?

Yes, Neoplasma is indexed in Web of Science (SCIE, Q3 quartile). Furthermore, in Scopus (SCImago), it holds an SJR rating of 0.586 (Q2) and an H-index of 62.

Who publishes Neoplasma and what is the Article Processing Charge (APC)?

Neoplasma is published by Vydavatel'stvo Slovenkej Akademie Vied/Veda Publishing House of the Slovak Academy of Sciences. The estimated Article Processing Charge (APC) is approximately $3,032 USD, subject to institutional waivers and corresponding author affiliations.

What is the ISO-4 abbreviation and acronym of Neoplasma?

The official ISO-4 abbreviation of Neoplasma is "NEOPLASMA". This standardized title abbreviation is used in citation lists conforming to IEEE, APA, Harvard, or Vancouver styles.

WoS SCIE Q3Scopus Q2SCImago #10,104Hybrid

Neoplasma

Abbreviation (ISO):NEOPLASMA

•

Identifier (ISSN):0028-2685(Print)/1338-4317(Online)

•

Publisher:Vydavatel'stvo Slovenkej Akademie Vied/Veda Publishing House of the Slovak Academy of Sciences

Official Website Submission Portal Compare

Clarivate IF (2026)

2.5↑ +0.3

Journal Impact Factor

IF Trend↓

WoS Quartile

WoS SCIEJCR Quartile

Clarivate WoS JCR

WoS Categories↓

JCR Release Date: 2026-06-17

Impact Factor Trend (2018–2026)

Clarivate IF trend for Neoplasma

WoS Q3

Annual Impact Factor Metric

Current (2026):2.5

Scopus SJR & RankScopus Q2

0.586

#10,104

SCImago Journal Rank citation prestige weighting

Scopus Year: 2025

H-Index (2025)

62 papers with at least that number of citations each

WoS: SCIE / JCRQ3

Self-Citation Rate0%

Safe Level (< 15%)Warning Level (> 20%)

Self-citation below 15% indicates strong scholarly independence.

Volume & Open AccessHybrid

143articles/year

4.14% Gold OA•92.59% Original Research

Aims & Scope

The journal Neoplasma publishes articles on experimental and clinical oncology and cancer epidemiology.

Topics Covered (Recognized by AI)

Biology93.7%Medicine93.1%Genetics86.5%Internal medicine81.6%Chemistry70.6%Biochemistry62.8%Pathology49.3%Cancer42.8%Immunology40.9%Cancer research37.4%Gene33.1%Surgery30.4%Physics23.8%Oncology22.2%Endocrinology21.8%Organic chemistry21.5%Molecular biology20.1%

Primary Research Areas

Medicine Oncology

Official Website NLM PubMed Catalog Submission Portal SCImago Profile

0 calls

Special Issues

Calls for Papers

No active Calls for Papers found for this journal.

Expand

WoS Categories & Quartiles

Detailed JCR / JCI category rankings and quartile breakdown from Clarivate

Clarivate JCR & JCI

JCRSCIE2026

ONCOLOGY

Rank204/333

IndexSCIE

JCISCIE2026

ONCOLOGY

Rank233/333

IndexSCIE

Category	Index	Rank	Quartile
ONCOLOGY	JCRSCIE	204/333	Q3
ONCOLOGY	JCISCIE	233/333	Q3

Annual Historical Statistics & Publications

Track annual publication volume, total citations, and Impact Factor evolution

12 year

2026Latest

IF2.5

Articles / Year24

Total Citations1

2025

IF2.2

Articles / Year50

Total Citations32

2024

IF2

Articles / Year54

Total Citations237

2023

IF3

Articles / Year67

Total Citations421

2022

IF3.409

Articles / Year122

Total Citations1,046

Year	Impact Factor	Articles / Year	Total Citations
2026	2.5	24	1
2025	2.2	50	32
2024	2	54	237
2023	3	67	421
2022	3.409	122	1,046
2021	2.575	132	1,326
2020	—	166	2,811
2019	1.771	119	2,496
2018	1.696	159	2,508
2017	—	103	1,899
2016	—	120	2,403
2015	—	141	2,383

SCImago & Scopus Journal Intelligence

Global SCImago ranking, SJR prestige index, Scopus coverage, and societal policy impact

Rank #10,104Scopus Q2SCImago Profile

Scopus Coverage:1957-2025

•

Scopus Broad Areas:Biochemistry, Genetics and Molecular BiologyMedicine

Scopus Citation Rank (SJR)Q2

0.586

Weighted prestige citation metric per document indexed in the Scopus database.

Quartile: Scopus Q2

Citations / Doc (2 years)

2.28

Average citations received per document published in the 2-year window.

2-Year Citation Window

Estimated Publication Fee (APC)

$3,032 USD

Estimated Article Processing Charge for Open Access publication.

Estimated cost / article

Scopus 3-Year Publication & Citation Window

3-Year Citations583

3-Year Documents266

Citable Documents265

Aggregated from Scopus database across the 3-year SJR evaluation window.

Societal Impact & Inclusivity (SCImago)

Policy Citations (Overton)0

Citations in government and international policy documents

Female Author Rate50.3%

Percentage of female authors published in the journal

Real-world societal policy reach and author gender diversity tracked by SCImago.

Scopus Subject Categories

Medicine (miscellaneous)Q2

Cancer ResearchQ3

OncologyQ3

Academic Metric Intelligence

Journal Metrics & Citation Visualizations

Total Cites vs Self-Cites

Evaluation of scholarly independence and citation reach

Total citations steady growth

Self-citation: 0%

Citations per Document

Citation metric windows across 2, 3, and 4 years

Cites / Doc (4 years)Cites / Doc (3 years)Cites / Doc (2 years)

Chinese Academy of Sciences (CAS) Classification

Major / minor zone classification and CAS Early Warning List history

Major Category (Broad Field):

4区 (Zone 4)Medicine

Minor Category (Specific Field):

4区ONCOLOGY

CAS Early Warning List History:

Updated annually: 2020 – 2024

2020

Not warned

2021

Not warned

2022

Not warned

2023

Not warned

2024

Not warned

Academic Intelligence Overview & Context

ImpaQ Analysis

Neoplasma (abbr: NEOPLASMA, ISSN: 0028-2685) is a peer-reviewed international scholarly journal in the field of Medicine, published by Vydavatel'stvo Slovenkej Akademie Vied/Veda Publishing House of the Slovak Academy of Sciences in Slovakia since 1957. The periodical holds a Journal Impact Factor (JIF) of 2.50, ranking in quartile Q3 of Web of Science (SCIE), a Scopus SJR indicator of 0.586 (Q2), an H-index of 62.

The journal enforces rigorous peer evaluation with a publication frequency of Bimonthly, an annual output of approximately 143 scientific articles. In terms of accessibility and author fees, it operates under the Hybrid model with an estimated APC of $3,032 USD. It serves as a benchmark publication platform for academics, researchers, and doctoral candidates seeking global research visibility.